Why Marijuana Edibles Could Be Another Big Disappointment for the Industry

Hexo Corp (TSX:HEXO) may not have as big of an advantage as it had hoped in the edibles market despite securing a deal with a big beverage maker.

| More on:

The edible marijuana market is launching in December, but it may not result in the boom that many are hoping or expecting for. Health Canada unveiled its plans for edibles and like its first launch of cannabis products, there will be some significant restrictions for cannabis companies.

Not only will advertising remain very limited, but it will create inefficiencies for companies that already make food products, as they’ll need a separate facility for cannabis edibles to avoid cross-contamination. Despite the concerns about restrictions on the industry, Bill Blair, who is responsible for the cannabis policy, said. “It’s not the government’s intention to promote the use of this drug, but rather to make it legally available in a well-regulated manner to reduce the social and health harms often associated with cannabis use.”

However, the danger is that by being so restrictive, it gives the black market a lot more power by providing consumers with more attractive and flexible options. One of the goals of marijuana legalization was to shift cannabis sales away from the underground. With cannabis prices already much more expensive and the difficulty of advertising and reaching consumers, it puts companies like Hexo Corp (TSX:HEXO) at a big disadvantage in relation to their U.S. counterparts.

While Hexo landed a deal with Molson Coors Canada, and although it will help the cannabis company develop infused beverages, it won’t be able to take advantage of its partner’s brand. Under the regulations, a cannabis product can’t be associated with an alcohol product. It negates one of the biggest potential benefits that cannabis companies had by linking up with successful beer makers: selling products with their popular logos.

Restrictive packing requirements means that Hexo won’t be able to have a co-branded product with Molson that can utilize the company’s image. It’s a big disadvantage for the company, especially when you look south of the border to states that have permitted cannabis where regulations are much looser, and companies can have a lot of freedom when it comes to advertising and marketing their products.

It’s no surprise that the industry has been doing so well there. With a much smaller population and more restrictions, the Canadian market looks much less appealing in comparison to its U.S. counterpart.

What this means for investors

From an investment standpoint, this tells me that even though Hexo may be one of the top cannabis companies in Canada, the better buy might be in the U.S., where there’s definitely a lot more growth potential for marijuana. The rollout of cannabis in Canada hasn’t been smooth, to say the least, and with many restrictions in place on edibles, it’s not going to get any better anytime soon.

These restrictions come with a liberal government in place that was strongly in favour of legalizing cannabis. We could see the industry throttled even further should conservatives get into power and try to impose even more requirements on companies.

Should you invest $1,000 in Hexo right now?

Before you buy stock in Hexo, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Hexo wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »